| abstract |
An object of the present invention is to provide a novel crystal of α-glucosyl hesperidin having a crystal structure and a powder substantially composed of the crystal, and use as a raw material of the pharmaceutical. The technical means for solving the problem is to provide a crystal of α-glucosyl hesperidin, the space group of which crystallizes is P21, and the lattice constant of the unit lattice is a=13.983A, b=7.620A, c=20.065A, and It is a monoclinic having α = γ = 90° and β = 93.475°, a powder substantially composed of the crystal, and a use as a raw material of the pharmaceutical. |